USPTO serial 99130062
TANTTI
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOINER, KATINA JACKSON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TANTTI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Feisthamel
Karen Feisthamel KDW Firm, PLLC2601 Weston Parkway, Suite 103Cary, NC 27513United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bacterial preparations except those for medical and veterinary use; agricultural chemicals except fungicides, herbicides, insecticides and parasite repellents; biological preparations for use in cell cultures, except those for medical and veterinary use; cultured microorganisms, except those for medical and veterinary use; non-medical and non-veterinary biological tissue cultures; nonmedical stem cells; culture media for stem cells for scientific use; chemical diagnostic reagents for industrial use; chemicals preparations for analyses in laboratories, other than for medical or veterinary purposes; culture media for microorganisms for non-medical and non-veterinary use; powdered cell culture media for scientific research use; unprocessed artificial resins; chemicals for differentiation of cell types | ACTIVE | — |
| 005 | Biological preparations for the prevention and treatment of cancer, infectious disease, viral infections, autoimmune diseases; medical microbial preparations; medical microbial culture media; medical biological tissue culture media; medical examination preparations, namely, diagnostic reagents for medical use, contrast agents for medical imaging, blood glucose test strips, pregnancy and fertility test kits, infectious disease detection kits, urinalysis test strips, allergy testing reagents, and hematology reagents; human medicines in the nature of vaccines for preventing infectious diseases, antidiabetic preparations for controlling blood glucose, cardiovascular preparations for treating hypertension and heart disease, oncology preparations for treating cancer; medical protein preparations in the nature of protein arrays for medical diagnosis purposes; nutritional supplements; agricultural medicines in the nature of vaccines for preventing infectious diseases in animals, insecticidal veterinary medicines for controlling parasites, nutritional veterinary supplements for promoting livestock health, and growth-promoting veterinary preparations; environmental sanitation medicines in the nature of disinfectant preparations for medical use and antimicrobial hand sanitizers; animal medicines in the nature of vaccines for preventing infectious diseases, nutritional veterinary supplements for promoting animal health, hormonal therapies for regulating reproduction and growth; air purification preparations; Stem cells for veterinary use | ACTIVE | — |
| 010 | Laboratory chromatography instruments, namely, gas chromatography apparatus for medical use; laboratory instruments, namely, blood pretreatment apparatus and instruments, medical centrifuges for separating blood components, cell separation instruments, dialysis apparatus, and urinalysis instruments; culture dishes, namely, laboratory antibody separation equipment; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and equipment for making and screening molecular arrays, and parts therefor; bacterial incubators, namely, laboratory instruments for reacting chemical or biological reagents; laboratory cell incubators for medical purposes. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 20, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 26, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 26, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 26, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 9, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 13, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 14, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 20, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 10, 2025 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |